Hepatitis viruses: Genetic variants and clinical significance

International Journal of Clinical and Laboratory Research

Volumn 27, Issue 4, 1997, Pages 213-224

  Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Genotypes; Hepatitis viruses; Mutants; Quasi species; Variants

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS VACCINE;

GENETIC VARIABILITY; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; ISOLATION AND PURIFICATION; MUTATION; REVIEW; VIRUS GENOME;

ANTIVIRAL AGENTS; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMANS; MUTATION; VARIATION (GENETICS); VIRAL HEPATITIS VACCINES;

EID: 0031408138     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050001     Document Type: Review

References (182)

1. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325: 1325.
2. Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993; 17: 361.
3. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454.
4. Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327: 910.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899.
6. Roudot-Thoraval F, Pawlotsky JM, Thiers V, Deforges L, Girollet PP, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 1993; 17: 772.
7. Thaler MM, Park CK, Landers DV, Wara DW, Houghton M, Veereman Wauters G, Sweet RL, Han JH. Vertical transmission of hepatitis C virus. 1991; 338: 17.
8. Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, Piazza S, Shih JW. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 1992; 117: 881.
9. Wejstal R, Widell A, Mansson AS, Hermodsson S, Norkrans G. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 1992; 117: 887.
10. Bresters D, Mauser Bunschoten EP, Reesink HW, Roosendaal G, Poel CL van der, Chamuleau RA, Jansen PL, Weegink CJ, Cuypers HT, Lelie PN, et al. Sexual transmission of hepatitis C virus. Lancet 1993; 342: 210.
11. Alter MJ. Inapparent transmission of hepatitis C: footprints in the sand (editorial). Hepatology 1991; 14: 389.
12. Ridzon R, Gallagher K, Ciesielski C, Mast EE, Ginsberg MB, Robertson BJ, Luo C-C, DeMaria A Jr. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997; 3: 919.
13. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335.
14. Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978; 75: 4533.
15. Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 1980; 77: 2941
16. Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980; 36: 829.
17. Sprengel R, Kaleta EF, Will H. Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 1988; 62: 3832.
18. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361: 742.
19. Medina T de, Haviv I, Noiman S, Shaul Y. The X protein of hepatitis B virus has a ribo/deoxy ATPase activity. Virology 1994; 202: 401.
20. Huang J, Kwong J, Sun EC-Y, Liang TJ. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol 1996; 70: 5582.
21. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 1340.
22. Chiagn PW, Jeng KS, Hu CP, Chang CM. Characterization of a cis element required for packaging and replication of the human hepatitis B virus. Virology 1992; 186: 701.
23. Huang J, Liang T. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 1993; 13: 7476.
24. Tavis JE, Perri S, Ganem D. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol 1994; 68: 3536.
25. Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403.
26. Wang GH, Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 1993; 67: 6507.
27. Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol 1994; 68: 6.
28. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359.
29. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527.
30. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381.
31. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277: 570.
32. Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 1997; 94: 8738.
33. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362.
34. Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501.
35. Zaaijer H, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722.
36. Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HGM, Lelie PN. International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 1996; 58: 175.
37. Pawlotsky J-M. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997; 26: 1.
38. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1996; 23: 1330.
39. Rizzetto M. The delta agent. Hepatology 1983; 3: 729.
40. Taylor J. Hepatitis delta virus. J Hepatol 1991; 13 [Suppl 4]: S114
41. Polish LB, Gallagher M, Fields HA, Hadler SC. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993; 6: 211.
42. Domingo E, Sabo D, Taniguchi T, Weissmann C. Nucleotide sequence heterogeneity of a RNA phage population. Cell 1978; 13: 735.
43. Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349.
44. Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 56.
45. Hasegawa K, Huang J, Rogers SA, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994; 68: 1651.
46. Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology 1989; 170: 595.
47. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325.
48. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckermann AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991; 13 [Suppl 4]: S105.
49. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. Loss of the common "a" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 1992; 90: 2543.
50. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992; 184: 1152.
51. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32: 264.
52. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 2671.
53. Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994; 169: 1374.
54. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Ostberg L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757.
55. Carman WF, Trautwein C, Deursen FJ van, Colman K, Dornan E, McIntyre G, Waters J, Kliem V, Müller R, Thomas HC, Manns MP. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489.
56. Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP, Meyer zum Bueschenfelde KH, Brechot C. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology 1991; 183: 555.
57. Fernholz D, Galle PR, Stemler M, Brunetto M, Bonino F, Will H. Infectious hepatitis B virus variant defective in preS2 protein expression in a chronic carrier. Virology 1993; 194: 137.
58. Minami M, Okanoue T, Nakajima E, Yasui K, Kagawa K, Kashima K. Significance of pre-S region-defective hepatitis B virus that emerged during exacerbation of chronic type B hepatitis. Hepatology 1993; 17: 558.
59. Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994; 199: 292.
60. Nakajima E, Minami M, Ochiya T, Kagawa K, Okanoue T. PreS1 deleted variants of hepatitis B virus in patients with chronic hepatitis. J Hepatol 1994; 20: 329.
61. Xu Z, Yen TSB. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol 1996; 70: 133.
62. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 1997; 26: 495.
63. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 94: 230.
64. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, Chisari FV, Rehermann B, Del Prete G, Fiaccadori F, Ferrari C. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996; 98: 1185.
65. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104.
66. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 1996; 23: 389.
67. Caselmann WH, Meyer M, Kekule AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 1990; 87: 2970.
68. Lauer U, Weiss L, Lipp M, Hofschneider PH, Kekule AS. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 1994; 19: 23.
69. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989: II: 588.
70. Brunetto MR, Stemler M, Bonino F, Schödel F, Oliveri F, Rizzetto M, Verme G, Will H. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 1990; 10: 258.
71. Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, Omi S, Okamoto H, Miyakawa Y, Mayumi M. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990; 99: 1113.
72. Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087.
73. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohio M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699.
74. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705.
75. Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992; 102: 538.
76. Okamoto Y, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298.
77. Omi S, Okamoto H, Tsuda F, Mayumi M. Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chmpanzees. J Gastroenterol Hepatol 1990; 5: 646.
78. Tur Kaspa R, Klein A, Aharonson S. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992; 16: 1338.
79. Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173.
80. Wakita T, Kakumu S, Shibata M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, Takayanagi M, Morishima T. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. J Clin Invest 1991; 88: 1793.
81. Ehata J, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992; 89: 332.
82. Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosoda K, Ohto M. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993; 91: 1206.
83. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407.
84. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472.
85. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29.
86. Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, Seito S, Thomas CH. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 1995; 22: 1628.
87. Fang JW, Tung FY, Davis GL, Dolson DJ, Van Thiel DH, Lau JY. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901.
88. McMillan JS, Bowden DS, Angus PW, McCaughan GW, Locarnini SA. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology 1996; 24: 1371.
89. Naumann U, Protzer-Knolle U, Berg T, Leder K, Lobeck H, Bechstein W-O, Gerken G, Hopf U, Neuhaus P A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis. Hepatology 1997; 26: 478.
90. Chen HS, Kew MC, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol 1992; 66: 5682.
91. Chuang WL, Omata M, Ehata T, Yokosuka O, Hosoda K, Imazeki F, Ohto M. Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklings. Hepatology 1994; 19: 569.
92. Pastore G, Santantonio T, Milella M, Monno L, Mariano N, Moschetta R, Pollice L. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: response to a 6-month course of lymphoblastoid interferon. J Hepatol 1992; 14: 221.
93. Santantonio T, Jung MC, Monno L, Milella M, Iacavazzi T, Pape GR, Pastore G, Will H. Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity. Arch Virol 1993; 8: 171.
94. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, Randone A, Abate ML, Manzini P, Capalbo M, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105: 845.
95. Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, Giustina G, Lai ME, Belussi F, Busatto G, et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584.
96. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230.
97. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester H, Stürzbecher HW, Hoeijmakers JHJ, Harris CC. Abrogation of p53-induced apoptosis by the hepatitis B virus x gene. Cancer Res 1995; 55: 6012.
98. Lee H, Lee Y-H, Huh Y-S, Moon H, Yun Y. X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem 1995; 270: 1405.
99. Lee T-H, Elledge SJ, Butel JS. Hepatitis B virus x protein interacts with a probable cellular DNA repair protein. J Virol 1995; 69: 1107.
100. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA 1995; 92: 11 215.
101. Blum HE, Zhang ZS, Galun E, Weizsäcker F von, Garner B, Liang TJ, Wands JR. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 1992; 66: 1223.
102. Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 1993; 195: 305.
103. Murakami S, Cheong JH, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 1994; 269: 15 118.
104. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993; 67: 1218.
105. Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994; 68: 2026.
106. Takada S, Koike K. Trans-activation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 1990; 87: 5628.
107. Wollersheim M, Debelka U, Hofschneider PH. A trans-activating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 1988; 3: 545.
108. Loncarevic IF, Zentgraf H, Schröder CH. Sequence of a replication competent hepatitis B virus genome with a preX open reading frame. Nucleic Acids Res 1990; 18: 4940.
109. Repp R, Keller C, Borkhardt A, Csecke A, Schaefer S, Gerlich WH, Lampert F. Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Arch Virol 1992; 125: 299.
110. Kim SH, Hong SP, Kim SK, Lee WS, Rho HM. Replication of a mutant hepatitis B virus with a fused X-C reading frame in hepatoma cells. J Gen Virol 1992; 73: 2421
111. Feitelson MA. Biology of hepatitis B virus variants. Lab Invest 1994; 71: 324.
112. Blum HE, Galun E, Liang TJ, Weizsäcker F von, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 1836.
113. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714.
114. Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711.
115. Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20.
116. Bain VG, Knetemann NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, Tipples G, Lee H, Jewell LD, Tyrrell DL. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
117. Aye TT, Bartholomeusz A, Shaw T, Breschkin AM, Gronen L, Bowden DS, McMillan JS, Angus PW, McCaughan GW, Locarnini SA. Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation. Hepatology 1996; 24: 285A.
118. Günther S, Baginski S, Kissel H, Reinke P, Kruher DH, Will H, Meisel H. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology 1996; 24: 751.
119. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka K, Miyakawa Y, Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68: 8102.
120. Baumert TF, Rogers SA, Hasegawa K, Liang TJ. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996; 98: 2268
121. Laskus T, Rakela J, Steers JL, Wiesner RH, Persing DH. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology 1994; 107: 1774.
122. Pult I, Chouard T, Wieland S, Klemenz R, Yaniv M, Blum HE. A hepatitis B virus mutant with a new hepatocyte nuclear factor binding site emerging in transplant transmitted fulminant hepatitis B. Hepatology 1997; 25: 1507.
123. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993; 90: 8234.
124. Okamoto H, Kanai N, Mishiro S. Fuli-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates. Nucleic Acids Res 1992; 20: 6410.
125. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Mtyakawa Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673.
126. Chan CY, Lee SD, Tsai YT, Lo KJ. Long-term follow-up of hepatitis B vaccination in susceptible hospital personnel. J Gastroenterol Hepatol 1992; 7: 266.
127. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992; 89: 7144.
128. Liu K, Hu Z, Li H, Prince AM, Inchauspe G. Genomic typing of hepatitis C viruses present in China. Gene 1992; 114: 245.
129. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina Selby R, Barr PJ, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451.
130. Brechot C, Kremsdorf D. Genetic variation of the hepatitis C virus (HCV) genome: random events or a clinically relevant issue? J Hepatol 1993; 17: 265.
131. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321.
132. Dusheiko G, Simmonds P. Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hepatitis 1994; 1: 3.
133. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992; 89: 4942.
134. Lee CH, Cheng C, Wang J, Lumeng L. Identification of hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region. J Clin Microbiol 1992; 30: 1602.
135. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392.
136. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183: 334.
137. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes (published erratum appears in J Hepatol 1992; 14: 435). J Hepatol 1992; 14: 35.
138. Dusheiko G, Schmilovitz Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19: 13.
139. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107.
140. Murakawa K, Esumi M, Kato T, Kambara H, Shikata T. Heterogeneity within the nonstructural protein 5′-encoding region of hepatitis C viruses from a single patient. Gene 1992; 117: 229.
141. Tanaka T, Kato N, Nakagawa M, Ootsuyama Y, Cho MJ, Nakazawa T, Hijikata M, Ishimura Y, Shimotohno K. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res 1992; 23: 39.
142. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S, Unoura M, Kobayashi K. Severity of liver disease with different hepatitis C viral clones (Letter). Lancet 1991; 338: 509.
143. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997; 25: 735.
144. Kurosaki M, Enomoto N, Sato C, Sakamoto N, Hoshino Y, Haritani H, Marumo F. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease. J Med Virol 1993; 39: 246.
145. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39: 234.
146. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996; 23: 676.
147. Zeuzem S, Franke A, Lee J-H, Herrman G, Rüster B, Roth WK. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996; 24: 1003.
148. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Ghemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211.
149. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JYN, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041.
150. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997; 25: 697.
151. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468.
152. Shimizu YK, Hijikata M, Twamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 1494.
153. Takada N, Matsuda Y, Takase S, Takada A, Date T. New genotypes of hepatitis C virus. Gastroenterol Jpn 1993; 28: 323.
154. Zein NN, Poterucha JJ, Gross JB Jr, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell S, Germer JJ, Persing DH. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996; 91: 2560.
155. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, Rossi S, Larghi A, Cerino A, Podda M, Mondelli MU. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754.
156. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta. Hepatology 1993; 18: 1319.
157. Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA (letter). Dig Dis Sci 1994; 39: 441.
158. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon (letter). Lancet 1992; 339: 1543.
159. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16: 619.
160. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293.
161. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250.
162. Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okundo T. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 1996; 24: 3018.
163. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96: 224.
164. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77.
165. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 1997; 25: 750.
166. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 1997; 25: 745.
167. Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 1997; 25: 740.
168. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, Virgilis S de. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996, 24: 1338.
169. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in northern European Caucasoids. Hepatology 1996; 24: 1342.
170. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825.
171. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. Hepatology 1997; 26: 485.
172. Ohno T, Lau JYN. The "gold-standard", accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology 1996, 24: 1312.
173. Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997; 112: 651.
174. Lai MM, Lee CM, Bih FY, Govindarajan S. The molecular basis of heterogeneity of hepatitis delta virus. J Hepatol 1991; 13 [Suppl 4]: S121.
175. Taylor JM. Human hepatitis delta virus. Curr Top Microbiol Immunol 1991; 168: 141.
176. Makino S, Chang MF, Shieh CK, Kamahora T, Vannier DM, Govindarajan S, Lai MM. Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature 1987; 329: 343.
177. Saldanha JA, Thomas HC, Monjardino JP. Cloning and sequencing of RNA of hepatitis delta virus isolated from human serum. J Gen Virol 1990; 71: 1603.
178. Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 1990; 64: 5594.
179. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 1993; 90: 9016.
180. Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM. Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992; 188: 265.
181. Wu JC, Choo KB, Chen CM Chen TZ, Huo TL Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995; 346: 939.
182. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997; 25: 728.